Eye Infections Treatment Market Worth USD 9.9 Bn by 2030 | Future Market Insights

Increasing prevalence of eye infections due to ocular surgical procedures is primarily shaping eye infection treatment market. A recent Future Market Insights (FMI) report forecasts that even though the eye infection treatment market would continue to experience a downtrend throughout 2022 due to COVId-19 pandemic, revenues would reach US$ 10 Bn by the end of 2030. Post-operative ocular infections remain among the most common eye infection types, says the FMI study.

Rising Caseloads

Caseloads of ocular surgical conditions such as cataracts, glaucoma, age-related macular degeneration (AMD), and diabetic retinopathy are growing due to sedentary lifestyle habits, and expanding geriatric cohort. According to the US statistics 2021, cataracts affect over 24 million Americans aging at least 40 years.

By age 75, about half of the Americans suffer from cataract. Further, diabetic retinopathy affects nearly 7.7 million Americans aging at least 40 years. In similar fashion, there were 48,229 corneal transplants performed in the US in 2015.

Demand for eye infection treatment will continue to receive a strong impetus from increasing awareness about different eye infection types and availability of treatment, further complemented by technological advancements on ophthalmology.

Request Sample PDF Brochure:

https://www.futuremarketinsights.com/reports/sample/rep-gb-1300

Key Takeaways of Eye Infection Treatment Market Study

  • Antibiotics would contribute over 55% revenue share in the eye infection treatment market owing to their use in treating primary eye infections and post-surgical eye infections.
  • Eye drop sales capture over 60% market share in the eye infection treatment market.
  • Conjunctivitis would account for a third of eye infection treatment demand through 2030.
  • Bacterial infections continue to account for over 3/5th market share.
  • Hospitals and retail pharmacies collectively generate over 70% total returns to shareholders.
  • Increasing rate of eye surgeries and rising usage of contact lenses continue to push North American market. European market would be upheld by the expanding geriatric pool.

Demand for Eye Infection Drugs to Slump Amidst COVID-19 Pandemic

The coronavirus (COVID-19) pandemic has resulted in widened gap between supply and demand of eye infection treatments. As such, it has significantly reduced ocular surgery rate for short-term basis and, in turn, post-operative eye infections.

According to World Health Organization (WHO), national healthcare resources redirection and utilization to contain COVID-19 pandemic is expected to delay and reschedule the treatment of non-critical healthcare conditions for brief period, including eye care services, and ocular surgeries.

Development and Licensing Deals with Multiple Commercialization Partners

Technology developers are laying greater emphasis on developing of novel ophthalmic formulation technologies and engaging with commercialization partners with licensing-out proprietary ophthalmic technologies.

For instance, Nicox S.A. has licensed out ZERVIATE (cetirizine ophthalmic solution) 0.24% to Eyevance Pharmaceuticals LLC for commercialization of ZERVIATE in the US. ZERVIATE is the first topical ocular formulation of antihistamine cetirizine approved for treatment of ocular itching associated with allergic conjunctivitis. In addition, Ocumension Therapeutics is responsible for all development and commercialization activities in Chinese market for ZERVIATE.

Ask for Customization:

https://www.futuremarketinsights.com/customization-available/rep-gb-1300

Key Segments:

By Drug Class :

  • Antibiotics
    • Sulfonamides
    • Macrolides
    • Erythromycin
    • Chloramphenicol
    • Aminoglycosides
    • Fluoroquinolones
    • Vancomycin
    • Tetracyclines
  • Antivirals
    • Thymidine-Based Nucleoside Analogues (Trifluridine)
    • Thymidine Phosphorylase Inhibitors (Trifluridine)
    • Acyclic Nucleoside Analogue of 2’Deoxyguanasine (Ganciclovir)
    • Acyclic Guanine Nucleoside Analog (Acyclovir)
    • Others
  • Antifungals
    • Polyenes (Amphotericin B (AMB) And Natamycin (NTM))
    • Azoles (Miconazole (MCZ), Econazole (ECZ) And Ketoconazole (KCZ))
    • Pyrimidines
    • Echinocandins (Caspofungin (CFG) and Micafungin (MFG))
    • Others
  • Antihistamines
  • Corticosteroids
  • Glucocorticoids

By Dosage Form :

  • Eye Infections Treatment Tablets
  • Eye Infections Treatment Capsules
  • Eye Infections Treatment Ophthalmic Ointments
  • Eye Infections Treatment Eye Drops
  • Others

By Indication :

  • Eye Infections Treatment for Conjunctivitis
  • Eye Infections Treatment for Keratitis
  • Eye Infections Treatment for Endophthalmitis
  • Eye Infections Treatment for Blepharitis
  • Eye Infections Treatment for Stye or Sty (Hordeolum)
  • Eye Infections Treatment for Uveitis
  • Eye Infections Treatment for Cellulitis
  • Eye Infections Treatment for Ocular Herpes

By Causative Agent :

  • Virus
  • Bacteria
  • Fungus
  • Allergens

By Distribution Channels :

  • Hospital Pharmacies
  • Retail Pharmacies
  • Online Pharmacies
  • Drug Stores

By Region :

  • North America Eye Infections Treatment Market
  • Latin America Eye Infections Treatment Market
  • Europe Eye Infections Treatment Market
  • East Asia Eye Infections Treatment Market
  • South Asia & Pacific Eye Infections Treatment Market
  • Middle East & Africa (MEA) Eye Infections Treatment Market

Get In Touch With Our Team For 20% Flat Discount:

https://www.futuremarketinsights.com/ask-question/rep-gb-1300

About Future Market Insights, Inc.

Future Market Insights, Inc. is an ESOMAR-certified business consulting & market research firm, a member of the Greater New York Chamber of Commerce and is headquartered in Delaware, USA. A recipient of Clutch Leaders Award 2022 on account of high client score (4.9/5), we have been collaborating with global enterprises in their business transformation journey and helping them deliver on their business ambitions. 80% of the largest Forbes 1000 enterprises are our clients. We serve global clients across all leading & niche market segments across all major industries.

Now avail flexible Research Subscriptions, and access Research multi-format through downloadable databooks, infographics, charts, interactive playbook for data visualization and full reports through MarketNgage, the market intelligence engine from Future Market Insights. Sign Up for a 7 day free trial!

Contact Us:

Future Market Insights, Inc.

Christiana Corporate, 200 Continental Drive,

Suite 401, Newark, Delaware – 19713, USA

T: +1-845-579-5705

Enquiries: sales@futuremarketinsights.com

LinkedIn| Twitter| Blogs

Ibuprofen API Market to Hit USD 772.2 Mn by 2029 | Future Market Insights

The global Ibuprofen API Market surpassed US$ 626.2 Mn in 2022 and is anticipated to increase at a CAGR of 3% to reach US$ 772.2 Mn by 2029. as per the findings of a new Future Market Insights (FMI) study. The primary factors for the growth of the Ibuprofen API market include continuous demand for low-cost non-steroidal anti-inflammatory drugs (NSAID) and the scale and age of manufacturing facilities.

Increasing API drug shortages and assembling a task force to overcome these problems, the emergence of cost-effective drug manufacturers in various countries and the supply of API drugs, primarily in developing countries, are further driving ibuprofen API market growth.

The pharmaceutical API industry is witnessing a substantial crunch in supply and demand of Ibuprofen API, halted production from major ibuprofen API manufacturers, and supply chain disruption in China further led by declining sales in India.

The volatility in Ibuprofen API is due to factors such as a lower number of competitors, reduced utilization ratio, lower margin level, new higher-value opportunities in complex combinations and high-grade API, the pace of facility inspection by FDA, and ramping up production capacity of through mergers and consolidation.

The diverse range of diseases, primarily cardiovascular disease, infectious diseases, diabetes, and kidney-related complications, has a high prevalence, globally. Thus, the increasing prevalence of a diverse range of diseases among all age groups and its burden, globally, drives the demand for drug development and its market.

There has been an upsurge in the usage of advanced technologies, such as high throughput, bioinformatics and combinatorial chemistry for better drug candidate identification. Drug discovery has evolved significantly with emerging technologies, helping the process to become more refined, accurate, and less time-consuming. Due to automation, multi-detector readers, imaging hardware and software, high-throughput screening is one of the most widely used drug discovery technologies.

Get Sample PDF Brochure:  

https://www.futuremarketinsights.com/reports/sample/rep-gb-11260

Leading Companies Profiled in Ibuprofen API Market are

  • BASF SE
  • BIOCAUSE Inc.
  • IOL Chemicals and Pharmaceuticals Limited
  • SI Group, Inc.
  • Sino-US Zibo Xinhua-Perrigo Pharmaceutical Co., Ltd.
  • Solara Active Pharma Sciences Limited
  • Granules India Limited

FMI Analyses the COVID-19 Impact on Market

FMI’s analysis suggests that the ongoing COVID-19 pandemic is having adverse impacts on market growth. Wuhan, China is the hub of API supplies. The region is the epicentre of the coronavirus outbreak, as such, it has temporarily halted its manufacturing facilities.

Further, China is the prominent or the sole supplier of APIs including, penicillin and erythromycin, in the world. Manufacturers and distributors in the country are blaming logistical barriers and labour scarcity due to the COVID-19 pandemic for the delay in production and transportation.

Key Takeaways of Ibuprofen API Market Study

  • Greater focus on relieving the pressure on the supply chain due to the demand gap is being tackled by ramping up production capacity, up-scaling is the fundamental strategy outlined for meeting demand in the Ibuprofen API space.
  • Majority of the anti-inflammatory drugs are manufactured in Asia, especially in China and India. Approximately 80% of the total anti-inflammatory APIs are manufactured in India and China and most of the APIs manufactured in these countries are outsourced to other developed regions – North America and Europe.
  • High upfront cost and lower margin level in Ibuprofen API have resulted in a 20-30% price spike in final drug formulations and lower sales in the previous year.
  • The market for Ibuprofen API is consolidated in nature, with leading manufacturers holding around 90% of the market value as 90%. Hence, the growing interest of CMOs and large-scale API manufacturers is anticipated to boost the value creation of the ibuprofen API market.
  • Higher volume handling by Contract Manufacturing Organizations in comparison to pharmaceutical companies and amid higher production capabilities and price advantage over pharmaceutical companies are expected to generate significant revenue pockets.
  • Expanding patient pool consuming non-controlled drugs as OTC are also responsible for the growth of in-house ibuprofen API consumption in South and East Asia.

Lower labour cost and abundant availability of raw materials required for ibuprofen API are among the key factors fuelling the growth of the ibuprofen API market in South Asia. In addition, favourable regulatory support to establish ibuprofen API manufacturing businesses, and lower taxation policies are boosting the growth of the East and South Asia ibuprofen API market.

Capacity Expansion, and Strategic Mergers & Acquisitions to Widen Regional Presence

Leading players in the ibuprofen API market – SI Group, Inc., BASF SE, Hubei Biocause Pharmaceutical Co., Ltd. (BIOCAUSE Inc.), IOL Chemicals, Sino-US Zibo Xinhua-Perrigo Pharmaceutical Co., Ltd., and Solara Active Pharma Sciences Limited – are focusing on business expansions by mergers, joint ventures, distribution agreements and capturing the untapped potential of the Ibuprofen API market.

  • In 2018, IOL Chemicals, the largest Indian Ibuprofen API manufacturer, expanded its production capacity to 12000 MT from the previous capacity of 7500 MT. With the increased capacity, IOL Chemicals is filling the demand-supply gap that is rising due to stringent regulatory reform in China. This move can further benefit the Indian manufacturers looking to strengthen their foothold in the Ibuprofen API market.
  • The acquisition by Solara Active Pharma Sciences Limited in 2018 of the Ibuprofen API assets of Strides and Sequent enabled the company to capture the portfolio of niche segments of the Ibuprofen API market.
  • The joint venture between Granules India Ltd (GIL) and Hubei Biocause Heilen Pharmaceutical Co. Ltd. have a production facility in Jingmen, China. In a recent discussion, Granules India Ltd (GIL) is planning to part out of the joint venture.

Additionally, current acquisitions are focused on capacity expansion, and manufacturing capabilities of existing Ibuprofen API players to gain competitiveness and accelerate revenue growth in the market landscape.

Ask for Customization:

https://www.futuremarketinsights.com/customization-available/rep-gb-11260

Table of Content

  1. Executive Summary

1.1. Global Market Outlook

1.2. Trends

1.3. Technology Roadmap

1.4. Analysis and Recommendations

  1. Market Overview

2.1. Market Coverage / Taxonomy

2.2. Market Definition / Scope / Limitations

2.3. Inclusions and Exclusions

  1. Key Market Trends

3.1. Key Trends Impacting the Market

3.2. Product Innovation / Development Trends

3.3. Strategic Promotional Strategies, By Key Manufacturers

Get In Touch With Our Team For 20% Flat Discount:

https://www.futuremarketinsights.com/ask-question/rep-gb-11260

About Future Market Insights, Inc.

Future Market Insights, Inc. is an ESOMAR-certified business consulting & market research firm, a member of the Greater New York Chamber of Commerce and is headquartered in Delaware, USA. A recipient of Clutch Leaders Award 2022 on account of high client score (4.9/5), we have been collaborating with global enterprises in their business transformation journey and helping them deliver on their business ambitions. 80% of the largest Forbes 1000 enterprises are our clients. We serve global clients across all leading & niche market segments across all major industries.

Now avail flexible Research Subscriptions, and access Research multi-format through downloadable databooks, infographics, charts, interactive playbook for data visualization and full reports through MarketNgage, the market intelligence engine from Future Market Insights. Sign Up for a 7 day free trial!

Contact Us:

Future Market Insights, Inc.

Christiana Corporate, 200 Continental Drive,

Suite 401, Newark, Delaware – 19713, USA

T: +1-845-579-5705

Enquiries: sales@futuremarketinsights.com

LinkedIn| Twitter| Blogs

Blood Fluid Warming System Market Moving Ahead With A CAGR Of 7.6% During The Forecast Period 2022-2032

In 2022, the global blood fluid warming system market is projected to be worth US$ 1,015.03 million. The industry is anticipated to reach a total value of about US$ 2,111.56 Million by 2032 after expanding at a CAGR of 7.6% between 2022 and 2032.

Hypothermia is a condition when the body temperature drops due to prolonged exposure to cold temperatures. The average body temperature is about 98.6 degrees Fahrenheit, basically with hypothermia the temperature drops below 95 degrees Fahrenheit.

Hypothermia usually occurs due to the steadiness between the body’s heat generation and heat loss proceed for heat loss for a prolonged period. To avoid hypothermia warm clothing is used for protection.

Also moderate environments can also lead to hypothermia, basically hypothermia depends on a person’s age, overall health, body fat, body mass and duration of time exposed to cold temperatures. However there are other medical conditions such as diabetes and thyroid conditions, severe trauma, or using drugs, other medications or alcohol content can increase the risk of hypothermia.

Sample of Research Report @ https://www.futuremarketinsights.com/reports/sample/rep-gb-1750 

Blood warmer is a medical device which is used to warm blood or fluids before transferring to a patient, basically the device works by warming blood to a temperature that is safe for infusion.

This device is usually used in emergency settings, intensive care units (ICU) and operating rooms so as to prevent hypothermia condition. The blood warmer consists significant features such as automatic adjustment of temperature to flow rate and easy to hear alarm system.

Blood/Fluid Warming System Market: Drivers and Restraints

The demand for blood/fluid warming system is fueled by increasing incidence of hypothermia cases. According to the Center for Disease Control (CDC) there are approximately 1,301 deaths caused due to hypothermia per year during the past decade. Increasing number of hypothermia cases in the cold countries is expected to boost the demand for blood/fluid warming systems during the forecast period.

The probability of hypothermia incidence is high in infants and geriatric population. Globally, it has been observed that the birth rate is increasing adding more infants to the existing population.

Likewise, the average life expectancy rare is also increasing which in turn is expected to boost the demand for blood/fluid warming systems market. The demand for blood/fluid warming systems is also increasing in regions with ice skating and tourism where rate of accidents and mishaps cause high exposure to cold temperature which in turn is increasing the demand for blood/fluid warming systems.

Increasing rate of surgical procedures performed on patients under anesthesia are also expected to promote demand for blood/fluid warming systems, ass patients under anesthesia cannot regulate their blood temperature blood/fluid warming systems are required to avoid complications related to unintended hypothermia.

Increasing incidence of diabetes, thyroid conditions and increasing rate of consumption of abusive drugs are some other factors responsible for causing hypothermia which in turn are expected to boost the demand for blood/fluid warming systems market.

However the low awareness of blood/fluid warming systems in the emerging countries may lead to slower market growth in these regions.

Request for Customization@ https://www.futuremarketinsights.com/customization-available/rep-gb-1750

Blood/Fluid Warming System Market: Overview

The blood/fluid warming systems market is largely penetrated by some key global players and is expected to witness healthy CAGR in terms of revenue owing to increasing applications and expansion in the patient pool suffering from chronic diseases like diabetes and geriatric population along with increasing number of surgical procedures performed globally.

The entry of new players and development of enhanced technology in the blood/fluid warming systems market is expected to create fierce competition in the market.

Blood/Fluid Warming System Market: Regional Overview

Geographically, the global Blood/Fluid Warming System market is classified into regions namely, North America, Latin America, Western Europe, Eastern Europe, Asia-Pacific excluding Japan (APEJ), Japan, Middle East and Africa (MEA).

North America dominates the global blood/fluid warming system market followed by Asia-Pacific and Europe. North America and Western Europe regions are expected to witness high growth due to increased adoption of blood/fluid warming systems and due to high incidence rate of hypothermia cases in these regions.

APEJ is expected to witness comparatively higher growth rate as compared to other regions, mainly due to high geriatric and diabetic population. Eastern Europe and Japan are also expected to gain substantial market growth due to clod temperature in these regions.

Latin America and MEA are expected to witness sluggish market growth due to lower incidence rate of hypothermia however increasing changing demographics and healthcare spending may boost the blood/fluid warming systems market in these regions during the forecast period.

Blood/Fluid Warming System Market: Key Players

Some of the major players operating in the market for Blood/Fluid Warming System are Emit Corporation, GE Healthcare, The 3M Company, Meridian Medical Systems, Smiths Medical, CareFusion, The 37Company, Barkey GmbH, Foshan Keewell and Becton, Dickinson and Company.

The report covers exhaustive analysis on

  • Market Segments
  • Market Dynamics
  • Market Size
  • Supply & Demand
  • Current Trends/Issues/Challenges
  • Competition & Companies involved
  • Technology
  • Value Chain

Contact our Market Research Specialist@ https://www.futuremarketinsights.com/askus/rep-gb-1750 

The report is a compilation of first-hand information, qualitative and quantitative assessment by industry analysts, inputs from industry experts and industry participants across the value chain.

The report provides in-depth analysis of parent market trends, macro-economic indicators and governing factors along with market attractiveness as per segments. The report also maps the qualitative impact of various market factors on market segments and geographies.

Blood/Fluid Warming System Market: Segmentation

The global blood/fluid warming system market is classified on the basis of product, distribution channel, application and regional presence.

Segmentation by Product

  • Surface warming system
  • Intravenous warming system
  • Patient warming accessories

Segmentation by Distribution channel

  • Hospitals
  • Clinics
  • E-Commerce

Segmentation by Application

  • Acute care
  • Preoperative care
  • New born care
  • Home care
  • Others

Top Related Reports Healthcare Market Insights

https://gezelligkletsen.nl/read-blog/11505

https://ai.wiki/read-blog/27536

https://jejaring.lokadaya.id/read-blog/2713

http://www.renexus.org/network/read-blog/87333

https://researchfmi.blogpostie.com/35905942/get-business-insights-on-the-coronary-stents-market-to-2026

About Future Market Insights (FMI) 

Future Market Insights (ESOMAR certified market research organization and a member of Greater New York Chamber of Commerce) provides in-depth insights into governing factors elevating the demand in the market. It discloses opportunities that will favor the market growth in various segments on the basis of Source, Application, Sales Channel and End Use over the next 10-years.

Contact:

Future Market Insights, Inc.
Christiana Corporate, 200 Continental Drive,
Suite 401, Newark, Delaware – 19713, USA
T: +1-845-579-5705
For Sales Enquiries: sales@futuremarketinsights.com
Browse All Reports: https://www.futuremarketinsights.com/reports
LinkedIn| Twitter| Blogs

Transcranial Doppler Ultrasounds System Market Innovations, Technology Growth and Research 2022-2032

Transcranial doppler ultrasounds system are medically used for quantitative measurement of blood flow velocity of the brain vessels. Transcranial doppler ultrasounds system are widely adopted in imaging diagnosis of stenosis, vasospasm, and emboli caused due to subarachnoid hemorrhage.

Transcranial Doppler ultrasounds system are also applied in recognition of arteriovenous malformations, cerebral circulatory arrest, sickle cell disorders, ischemic cerebrovascular disorder, and subarachnoid hemorrhage. Transcranial doppler ultrasounds system has applications in perioperative monitoring and meningeal infection.

Transcranial doppler ultrasounds system tests are often used in association with MRA, MRI, CT scan, and carotid duplex ultrasound tests. Transcranial doppler ultrasounds system are based on two technology, first, b-mode imaging technology, which present 2-D images of brain, skull, and blood vessels, second, doppler imaging technology, which represents graphical view of velocity over the time interval, on combination produces a duplex test.

Request a Sample of this Report @ https://www.futuremarketinsights.com/reports/sample/rep-gb-5139

Transcranial Doppler Ultrasounds System Market: Drivers and Restraints

The growth of global transcranial doppler ultrasounds system market is generally driven by rising prevalence and incidence rate of hemorrhage, and other disorders such as sickle cell disorders, cerebral circulatory arrest and others. Moreover, other factors such as increasing healthcare expenditure and adoption of technologically advanced products on the global level are also gardening the growth of transcranial doppler ultrasounds system market.

However, high cost of products and low availability of skilled personnel are the major handles in the market growth of transcranial doppler ultrasounds system. In addition to that, transcranial doppler ultrasounds system are insufficient in providing precise results due to relative velocity of blood flow, this may result in lowering the market growth of transcranial doppler ultrasounds system.

Transcranial Doppler Ultrasounds System Market: Overview

Transcranial doppler ultrasounds system are non-invasive technology for evaluating blood current velocity in basal intracranial arteries. Transcranial doppler ultrasounds systems are used in combination with different imaging modalities. Since its introduction, various technological advancement has been witnessed in transcranial doppler ultrasounds system for bordering its application range.

These systems are also used in point-of-care services for real-time monitoring and can boost the market growth of transcranial doppler ultrasounds system.

Transcranial Doppler Ultrasounds System Market: Region Wise Outlook

Geographically, transcranial doppler ultrasounds system market is classified into regions viz. North America, Latin America, Western Europe, Eastern Europe, Asia-Pacific, Japan, Middle East and Africa. The market in North America is anticipated to hold the largest share of transcranial doppler ultrasounds system in the global market, followed by Western Europe, owing to the presence of sophisticated healthcare facilities and increased adoption in hospitals and diagnostic imaging clinics.

In addition, they are also adopted for point-of-care monitoring and can result in driving the growth of transcranial Doppler ultrasounds system market. The market in Asia- Pacific region and Japan is anticipated to grow at a higher rate owing to the rising research and development investment from private and public bodies and rapidly evolving healthcare infrastructure.

However, the market in regions such as Latin America, Eastern Europe, and Middle East and Africa are estimated to show a stagnant growth over the forecast period owing to the low per capita income and inadequate presence of healthcare facilities.

Request for Customization@ https://www.futuremarketinsights.com/customization-available/rep-gb-5139

Transcranial Doppler Ultrasounds System Market: Key Players

Some of the market participants in the global transcranial doppler ultrasounds system market are ELCAT, Rimed, Natus Medical Incorporated, SMT medical GmbH & Co. KG, Neural Analytics, Recorders & Medicare Systems P Ltd., DX-systems, Elica, Multigon Industries, Inc., and Atys Medica.

The report is a compilation of first-hand information, qualitative and quantitative assessment by industry analysts, inputs from industry experts and industry participants across the value chain. The report provides in-depth analysis of parent market trends, macro-economic indicators and governing factors along with market attractiveness as per segments. The report also maps the qualitative impact of various market factors on market segments and geographies.

The report covers exhaustive analysis on

  • Market Segments
  • Market Dynamics
  • Market Size
  • Current Trends/Issues/Challenges
  • Competition & Companies involved
  • Value Chain

The regional analysis includes

  • North America (U.S., Canada)
  • Latin America (Mexico. Brazil)
  • Western Europe (Germany, Italy, France, U.K, Spain, Nordic countries, Belgium, Netherlands, Luxembourg)
  • Eastern Europe (Poland, Russia)
  • Asia-Pacific (China, India, ASEAN, Australia & New Zealand)
  • Japan
  • The Middle East and Africa (GCC, S. Africa, N. Africa)

The report is a compilation of first-hand information, qualitative and quantitative assessment by industry analysts, inputs from industry experts and industry participants across the value chain. The report provides in-depth analysis of parent market trends, macroeconomic indicators and governing factors along with market attractiveness as per segments. The report also maps the qualitative impact of various market factors on market segments and geographies.

Contact our Market Research Specialist @ https://www.futuremarketinsights.com/askus/rep-gb-5139 

Transcranial Doppler Ultrasounds System Market: Segmentation

The global transcranial doppler ultrasounds system market can be segmented on the basis of product type, component type, modality type, end-user, and region.

On the basis of product type, global transcranial doppler ultrasounds system market can be segmented as:

  • Wearable
  • Non-Wearable

On the basis of component type, global transcranial doppler ultrasounds system market can be segmented as:

  • Systems
  • Accessories

On the basis of modality type, global transcranial doppler ultrasounds system market can be segmented as:

  • Standalone
  • Portable

On the basis of end-user, global transcranial doppler ultrasounds system market can be segmented as:

  • Hospital
  • Imaging Diagnostic Centers
  • Ambulatory Surgical Centers
  • Others

On the basis of region, global transcranial doppler ultrasounds system market can be segmented as:

  • North America
  • Latin America
  • Western Europe
  • Eastern Europe
  • Asia Pacific Excluding Japan
  • Japan
  • Middle East and Africa

Top Related Reports Healthcare Market Insights

https://myjoye.com/blogs/773/3361/coronary-stents-market-creating-opportunity-demands-supply

https://justnock.com/read-blog/10440

https://loop.joshwho.net/posts/28032840?utm_source=manual

https://www.xaphyr.com/blogs/160523/Coronary-Stents-Market-Segmentation-Application-Technology-Analysis-Research-Report-To

https://app.goodnightjournal.com/journal/3ccc4fce-b1d4-418a-92b2-d1d36053f3bf

https://www.zedlike.com/blogs/18876/Coronary-Stents-Market-Value-With-Status-And-Global-Analysis-Future

About Future Market Insights (FMI) 

Future Market Insights (ESOMAR certified market research organization and a member of Greater New York Chamber of Commerce) provides in-depth insights into governing factors elevating the demand in the market. It discloses opportunities that will favor the market growth in various segments on the basis of Source, Application, Sales Channel and End Use over the next 10-years.

Contact:

Future Market Insights, Inc.
Christiana Corporate, 200 Continental Drive,
Suite 401, Newark, Delaware – 19713, USA
T: +1-845-579-5705
For Sales Enquiries: sales@futuremarketinsights.com
Browse All Reports: https://www.futuremarketinsights.com/reports
LinkedIn| Twitter| Blogs

Angiographic Catheters Market Research, Segmentation, Key Players Analysis & Forecast By 2032

The global angiographic catheters market is anticipated to grow from US$ 1,402.8 million in 2022 to US$ 2,094.4 million in 2032, at a CAGR of 3.7%.

Angiographic catheter is used in the angiographic procedures. The angiographic catheters provides therapeutic agents and radiopaque media to the selected sites in vascular system. In addition, the angiographic catheter is also used to lead a guide wire to the targeted site. Angiographic catheters is used for the treatment of cardiac diseases. The thin wall structure of the catheter allows the flow rate up to 23 ml/sec (saline). Angiographic catheters are basically made from the polyamide, polyethylene, polyurethane, and polytetrafluoroethylene.The silicone coated urinary catheters are being served as the reference standards.

Angiographic catheters are available in different shapes. An angiographic catheters have only one end hole. The use of an angiographic catheter helps to combine the diagnosis and treatment in a single procedure. Angiographic catheters produces a very clear, detailed and accurate pictures of the blood vessels. The angiographic catheters also eliminates the need of any surgery. Angiographic catheters are medical devices which are is specifically used for the diagnosis of a heart defect or of the central circulatory system.

Angiographic Catheters Market: Drivers and Restraints

The increasing incidence of cardiac vascular diseases (CVDs) and rise in demand of accurate diagnosis and procedural equipment’s in global healthcare sector is increasing the demand for angiographic catheters and will lead to the growth of the global angiographic catheters market. In addition, increase in ageing population and lifestyle changes leading to hypertension, obesity, and other risk factors that lead to vascular disorders, is expected to propel the growth of the angiographic catheters market.

Request a sample @ https://www.futuremarketinsights.com/reports/sample/REP-GB-6053

However, high cost of angiographic procedures and other components may hamper the growth of the global angiographic catheters market. Furthermore, the availability of alternative therapies, and complications associated with angiographic catheters can restrain the growth of the global angiographic catheters market.

Angiographic Catheters Market: Overview

The global market for angiographic catheters is expected to witness moderate growth over the forecast period due to increasing adoption of angiographic procedures. Angiographic catheter is a surgically invasive device which is intended for the transient use. The device is specifically used for the diagnosis of a heart defect or of the central circulatory system.

External factors such as increasing use of e-commerce and logistics services in developing and under developing economies are also increasing the market growth of angiographic catheters. Based on the product type, the global angiographic catheters market is segmented into scoring balloon catheters and cutting balloon catheters. Based on end user, the market is segmented into hospitals, ambulatory surgical centres, specialty clinics and others. Hospital segment holds the maximum market share for the angiographic catheters market.

Angiographic Catheters Market: Regional Outlook

Geographically, global Angiographic Catheters Market is classified into regions viz. North America, Latin America, Western Europe, Eastern Europe, Asia-Pacific, Japan, Middle East and Africa. North America is expected to dominate global angiographic catheters market over the forecast period due to the increasing incidences of cardio vascular diseases in this region.

Ask an Analyst@ https://www.futuremarketinsights.com/ask-question/REP-GB-6053

Western Europe is expected to be the second largest market for angiographic catheters due to the increasing government support for people undergoing coronary angioplasty through reimbursement and thus increasing the adoption of angioplasty catheters in the region. Asia Pacific market is expected to experience delayed growth due to unawareness towards use of angiographic catheters and low disposable income.

Angiographic Catheters Market: Key Players

Some of the players identified in global angiographic catheters market include AngioDynamics, Inc., Terumo Europe NV, Medtronic, Merit Medical Systems, Inc., OSCOR Inc., B. Braun Melsungen AG, Cardinal Health,  InSitu Technologies Inc., BVM Medical Limited, Precision Extrusion Inc., Cardiva, C. R. Bard, Inc., Boston Scientific Corporation  and others. During the recent years, manufacturers have improved the surface properties of angiographic catheters.

The research report presents a comprehensive assessment of the market and contains thoughtful insights, facts, historical data, and statistically supported and industry-validated market data. It also contains projections using a suitable set of assumptions and methodologies. The research report provides analysis and information according to market segments such as geographies, application, and industry.

The report covers exhaust analysis on:

  • Market Segments
  • Market Dynamics
  • Market Size
  • Supply & Demand
  • Current Trends/Issues/Challenges
  • Competition & Companies involved
  • Technology
  • Value Chain

Ask For Customization@ https://www.futuremarketinsights.com/customization-available/REP-GB-6053

The report is a compilation of first-hand information, qualitative and quantitative assessment by industry analysts, inputs from industry experts and industry participants across the value chain. The report provides in-depth analysis of parent market trends, macro-economic indicators and governing factors along with market attractiveness as per segments. The report also maps the qualitative impact of various market factors on market segments and geographies.

Angiographic Catheters Market: Segmentation

Tentatively, global angiographic catheters market has been segmented on the basis of product type, end user, and geography.

Based on product type, global angiographic catheters market is segmented as below:

  • Scoring balloon catheters
  • Cutting balloon catheters

Based on end user, global angiographic catheters market is segmented as below:

  • Hospitals
  • Ambulatory Surgical Centers
  • Specialty clinics
  • Others

Top Related Reports Healthcare Market Insights

https://community.wongcw.com/blogs/213126/Coronary-Stents-Market-To-Undertake-Strapping-Growth-By-The-End

https://wakelet.com/wake/cG-qYeg3KiqhpBFBAzWrj

https://kaalama.org/read-blog/192537

https://bookmarksmywebs.com/coronary-stents-market-research-segmentation-key-players-analysis-forecast-by-2026/

https://healthcarefmi.blogspot.com/2022/10/coronary-stents-market-global-analysis.html

https://healthandfitness901316.blogspot.com/2022/10/coronary-stents-market-report-overview.html

About Future Market Insights (FMI) 

Future Market Insights (ESOMAR certified market research organization and a member of Greater New York Chamber of Commerce) provides in-depth insights into governing factors elevating the demand in the market. It discloses opportunities that will favor the market growth in various segments on the basis of Source, Application, Sales Channel and End Use over the next 10-years.

Contact:

Future Market Insights, Inc.
Christiana Corporate, 200 Continental Drive,
Suite 401, Newark, Delaware – 19713, USA
T: +1-845-579-5705
For Sales Enquiries: sales@futuremarketinsights.com
Browse All Reports: https://www.futuremarketinsights.com/reports
LinkedIn| Twitter| Blogs

Temporary Pacing Leads Market Expectations & Growth Trends Highlighted 2022-2032

The Temporary pacing leads market is expected to show significant growth over the forecast period due to increasing prevalence of cardiovascular disease globally. According to World Health Organization, 17.5 Mn people died in 2016 from cardiovascular diseases. World Health Organization also stated that more than 75% cardiovascular disease occur in low-income countries which is the opportunity for temporary pacing leads market to grow in Middle East region. Among all end user, hospital segment will dominate the market for temporary pacing leads over the forecast period as the majority cardiac diseases are treated at hospitals. Leading manufacturer of temporary pacing leads focusing to expand their regional presence in the emerging geographies such as APAC and MEA by collaborating with the distributers.

The temporary pacing lead, a small catheter with two electrodes. It is placed in the right ventricle of the heart through a vein in the groin or neck. The lead of temporary pacing leads is connected to an external pacemaker which also the physician to monitor and control the heart rate of patients. Temporary pacing leads emits electrical stimulus to heart for producing the depolarization of cardiac cells.

Download Sample Copy@ https://www.futuremarketinsights.com/reports/sample/rep-gb-5861

Temporary pacing leads used when a permanent pacemaker is either not necessary or is not immediately available. Temporary pacing lead include two components viz. conductive leads and electrode wire. The implantation of temporary pacing leads in the epicardium or myocardial tissue of the atria or ventricles of the cardiac patient’s heart is a typical surgery for the surgeon.

Temporary Pacing Leads Market : Dynamics

The increase prevalence of cardiac disease led is the primary factor responsible for the growth of temporary pacing leads market. According to the American Heart Association, globally over 80 million people suffering from heart health problems. This is occurring due to change in life style of people and consumption of high amount of fats and sugar.

Rising preference of cardiologist for the use of temporary pacing to re-establish circulatory integrity and normal hemodynamics will significantly drive the growth of this market. Rising geriatric population and increased demand for minimally invasive surgeries are expected to drive temporary pacing leads market globally. The lack of skilled profession and less awareness among the people in undeveloped economies will lead to sluggish growth of this market. The high prices of temporary pacing leads high risk of complication during the surgeries can also deter the growth of this market.

Temporary Pacing Leads Market: Key Players

Examples of some of the market participants in Temporary Pacing Leads market identified across the value chain include Medtronic plc, OSCOR Inc, B. Braun Melsungen AG, Biotronik, Sorin Group, Biosensors, Vitatron, Estech, Greatbatch Medical and others.

Request for Customization@ https://www.futuremarketinsights.com/customization-available/rep-gb-5861

The research report presents a comprehensive assessment of the market and contains thoughtful insights, facts, historical data, and statistically supported and industry-validated market data. It also contains projections using a suitable set of assumptions and methodologies. The research report provides analysis and information according to market segments such as geographies, application, and industry.

The report covers exhaust analysis on:

  • Market Segments
  • Market Dynamics
  • Market Size
  • Supply & Demand
  • Current Trends/Issues/Challenges
  • Competition & Companies involved
  • Technology
  • Value Chain

Regional analysis includes:

  • North America (U.S., Canada)
  • Latin America (Mexico. Brazil)
  • Western Europe (Germany, Italy, France, U.K, Spain)
  • Eastern Europe (Poland, Russia)
  • Asia Pacific (China, India, ASEAN, Australia & New Zealand)
  • Japan
  • Middle East and Africa (GCC Countries, S. Africa, Northern Africa)

The report is a compilation of first-hand information, qualitative and quantitative assessment by industry analysts, inputs from industry experts and industry participants across the value chain. The report provides in-depth analysis of parent market trends, macro-economic indicators and governing factors along with market attractiveness as per segments. The report also maps the qualitative impact of various market factors on market segments and geographies.

Speak to our Research Expert@ https://www.futuremarketinsights.com/ask-question/rep-gb-5861

Temporary Pacing Leads Market: Segmentation

Based on product type, Temporary Pacing Leads market is segmented into following:

  • Unipolar Temporary Pacing Leads
  • Bipolar Temporary Pacing Leads

Based on technique, Temporary Pacing Leads market is segmented into following:

  • Transcutaneaous Pacing
  • Transvenous Pacing
  • Epicardial Pacing

Based on end user, Temporary Pacing Leads market is segmented into following:

  • Hospitals
  • Ambulatory Surgical Centers
  • Cardiac Catherization Centers

Top Related Reports Healthcare Market Insights

https://www.pressreader.com/article/6755777415044413

https://www.letsdiskuss.com/post/coronary-stents-market-latest-advancements-and-business-opportunities-up-to-2026

https://www.scoop.it/topic/automotive-by-vishal-58/p/4136900334/2022/10/17/coronary-stents-market-revenue-future-and-business-analysis-by-forecast-2026?&kind=crawled&fId=1081630

https://odlook.com/post/6623_the-demand-for-interventional-cardiology-care-is-being-fueled-by-the-rising-prev.html

https://london-news-community.tribeplatform.com/general/post/coronary-stents-market-swot-analysis-dynamics-drivers-key-indicators-IbJnoTR9JkA7a1l

https://club.vexanium.com/post/the-demand-for-interventional-cardiology-care-is-being-fueled-by-the-rising–634d470d2a79279ae79b51da

About Future Market Insights (FMI) 

Future Market Insights (ESOMAR certified market research organization and a member of Greater New York Chamber of Commerce) provides in-depth insights into governing factors elevating the demand in the market. It discloses opportunities that will favor the market growth in various segments on the basis of Source, Application, Sales Channel and End Use over the next 10-years.

Contact:

Future Market Insights, Inc.
Christiana Corporate, 200 Continental Drive,
Suite 401, Newark, Delaware – 19713, USA
T: +1-845-579-5705
For Sales Enquiries: sales@futuremarketinsights.com
Browse All Reports: https://www.futuremarketinsights.com/reports
LinkedIn| Twitter| Blogs

Topical Wound Agents Market is Poised to Exhibit A Moderate 6.6% CAGR through 2022-2032

The topical wound agents market is anticipated to reach US$ 3.0 million in sales by 2032, up from US$ 1.5 million in 2022, with a CAGR of 6.6% over the forecast period.

The global topical wound agents market has witnessed robust growth due to rising prevalence of chronic wounds in all age groups. Topical wound agents market is a witness to the presence of many local players which hold a huge market share in the Topical Wound Agents Market. There are huge opportunities for the manufacturers due to the large number of patients suffering from both acute and chronic wounds.

The key players in the topical wound agents market are mainly focused on R&D to accelerate the development of novel drugs to increase their market share. Improved accessibility to healthcare services along with increasing awareness in patient population is expected to boost the growth of the topical wound agents market in developing economies. The topical wound agents market is anticipated to grow with double digit CAGR during the forecast period. Topical wound agents are medical preparations used to treat dermatological injuries. Topical wound agents are mainly formulated into emulsions, creams, oils, spray and others.

Request a sample @ https://www.futuremarketinsights.com/reports/sample/rep-gb-6893

A wide variety of agents are used for the management of both acute and chronic wounds. Topical wound agents are mainly used for controlling inflammation, infection and pain. NSAIDs & Analgesics were used to treat inflammation & pain. However, wound healing is a complex progress and is affected by both intrinsic and extrinsic factors. Infection delays the healing process and increases the risk of infections. To control the infection, mainly disinfectants are used and they are active against disease-causing microorganisms and include antiseptics and antibiotics.

Antiseptics are broad-spectrum antimicrobials used to treat intact skin or open wounds. Antibiotics are agents that kill or inhibit the growth of microorganisms and are used against specific cells (narrow broad spectrum). Antibiotics are more susceptible to bacterial resistance and require a continuous change in treatment regimen. Topical antibiotics are more advantageous than systemic antibiotics due to fewer side effects and limited dosage errors.

Topical Wound Agents Market:

Drivers and Restraints

Rising prevalence of chronic wounds across the world will promote the growth of the topical wound agents market. Chronic wounds have a significant impact on quality of life, can lead to functional impairments as well as huge economic burdens. According to Wound Australia, the prevalence of chronic wounds is estimated to be from 1.1% to 26.7% in the hospital setting and it is around 6% to 29% in community setting.

The economic burden of wound treatment is also very high, for example, annual treatment of managing wounds in the NHS has been estimated to be Euro 5.3 Bn. To control prevalence and this economic burden, governments have initiated many actions plans for wound management.

Along with government initiatives, growing awareness about wound infections among the general population is fuelling the growth of the topical wounds agents market. Apart from these, increasing healthcare funding and improving healthcare facilities will also support the burgeoning growth of topical wound agents market.

Rising antibiotics concerns and lack of epidemiological data will restrain the growth of the topical wound agents market.

Topical Wound Agents Market: Region-Wise Overview

The global topical wound agents market can be segmented into the following regions: North America, Latin America, Western Europe, Eastern Europe, Asia-Pacific Excluding China & Japan, China, Japan and the Middle East and Africa. North America is dominant in the Global Topical Wound Agents market, mainly due to high awareness among the patient population.

Request for Customization@ https://www.futuremarketinsights.com/customization-available/rep-gb-6893

In North America, particularly the USA will hold the dominant position, mainly due to the high penetration. Economic conditions in the APAC region are set to drive the Topical Wound Agents market to new heights. APAC & Latin America is the fastest growing region in topical wound agents market due to improved healthcare services. Growth in the Middle East and African region is considerably less when compared to the other regions.

However, North America would maintain its position in the Topical Wound Agents market and it is anticipated that emerging economies, such India, China, Brazil & Mexico, will witness highest growth rate in the Topical Wound Agents market.

Topical Wound Agents Market: Key Participants

Some of the key participants in the Topical Wound Agents market include Teva Pharmaceutical Industries Ltd., Novartis AG, Pfizer Inc., Johnson & Johnson, Mylan N.V., AstraZeneca Plc. and others. Companies are focused on formulating new dosage forms to increase the adoption of topical wound agents.

The research report presents a comprehensive assessment of the market and contains thoughtful insights, facts, historical data, and statistically supported and industry-validated market data. It also contains projections using a suitable set of assumptions and methodologies. The research report provides analysis and information according to market segments such as geographies, application, and industry.

Ask an Analyst@ https://www.futuremarketinsights.com/ask-question/rep-gb-6893

Topical Wound Agents Market: Segmentation

Segmentation of Topical Wound Agents Market based on Drug Type

  • NSAIDS
  • Antiseptics
  • Antibiotics
  • Others

Segmentation of Topical Wound Agents Market based on Dosage Forms

  • Creams
  • Lotions
  • Powders
  • Emulsions
  • Gels
  • Others

Segmentation of Topical Wound Agents Market based on Distribution Channel

  • Hospital Pharmacies
  • Retail Pharmacies/Drugstores
  • E-Commerce

Report Highlights:

  • Detailed overview of parent market
  • Changing market dynamics in the industry
  • In-depth market segmentation
  • Historical, current, and projected market size in terms of volume and value
  • Recent industry trends and developments
  • Competitive landscape
  • Strategies of key players and products offered
  • Potential and niche segments, geographical regions exhibiting promising growth
  • A neutral perspective on market performance
  • Must-have information for market players to sustain and enhance their market footprint

Top Related Reports Healthcare Market Insights

https://medium.com/@vishal.tupkar/the-demand-for-interventional-cardiology-care-is-being-fueled-by-the-rising-prevalence-of-coronary-61ea702feab6

https://www.evernote.com/shard/s703/client/snv?noteGuid=ddd632d7-bb66-ab26-a73e-99039864d0d0&noteKey=51a248a52e59aab4ccce85498e0fd3e9&sn=https%3A%2F%2Fwww.evernote.com%2Fshard%2Fs703%2Fsh%2Fddd632d7-bb66-ab26-a73e-99039864d0d0%2F51a248a52e59aab4ccce85498e0fd3e9&title=Coronary%2BStents%2BMarket%2BFuture%2BTrends%252C%2BIndustry%2BSize%2Band%2BForecast%2Bto%2B2026

https://www.tumblr.com/researchvishal/698360697662373888/coronary-stents-market-analysis-by-size-share?source=share&_branch_match_id=1092693908979658921&_branch_referrer=H4sIAAAAAAAAAw3K6wqDMAwG0CdKg4hs%2BjZpydZiL%2FIlCu7p5%2B9zsvthG7N48LPFipBGY6ipIOWrWJbKaWB0wU3m2t2oCXZ1ki71tmIUHyk%2FpSdD%2Bb1O%2Fn1h2TF%2F%2FiFbQJBfAAAA

https://www.xing.com/discover/detail-activities/6720565465.cdb6ba

https://www.spoke.com/topics/coronary-stents-market-future-scenario-key-insights-top-companies-2026-634d468000d3e321240203bd

About Future Market Insights (FMI) 

Future Market Insights (ESOMAR certified market research organization and a member of Greater New York Chamber of Commerce) provides in-depth insights into governing factors elevating the demand in the market. It discloses opportunities that will favor the market growth in various segments on the basis of Source, Application, Sales Channel and End Use over the next 10-years.

Contact:

Future Market Insights, Inc.
Christiana Corporate, 200 Continental Drive,
Suite 401, Newark, Delaware – 19713, USA
T: +1-845-579-5705
For Sales Enquiries: sales@futuremarketinsights.com
Browse All Reports: https://www.futuremarketinsights.com/reports
LinkedIn| Twitter| Blogs

Behavioural Health Market is expected to be valued at US$ 156.3 Bn by 2028 end

[241 Pages Report] According to the latest market report published by Future Market Insights titled “Behavioural Health Market: Global Industry Analysis 2013–2021 and Opportunity Assessment 2022–2028”, the global behavioural health market is expected to expand at 3.4% CAGR over the forecast period 2022-2028.

North America is expected to hold the highest revenue share in the global behavioural health market over the forecast period. Currently, over 43.8 million adults in the U.S. are suffering from mental illness, which is fuelling demand for behavioral health services. Developing economies are witnessing large demand for home care services, day care services, and internet-counselling services, which is further expected to boost revenue growth of the behavioural health market in emerging markets.

Behavioral Health Market Size (2022) US$ 128.2 Bn
Projected Behavioral Health Market Value (2028) US$ 156.3 Bn
Global Behavioral Health Market Growth Rate (2022-2028) 3.4% CAGR
Region With Dominant Behavioral Health Market Share North America
Global Behavioural Health Market: Segmental Analysis & Forecast

The global behavioural health market is segmented based on service type, disorder type, and region. Based on service type the market is segmented into outpatient counselling, intensive case management, home-based treatment services, inpatient hospital treatment, emergency mental health service and others. The inpatient hospital treatment services type segment is expected to represent highest revenue share in the global behavioural health market. Home-based treatment services are expected to gain popularity among people in the coming years and this segment is expected to expand at a CAGR of 4.0% over the forecast period.

Based on disorder type the market is segmented into the anxiety disorder, bipolar disorder, depression, eating disorder, post-traumatic stress disorder (PSTD), substance abuse disorder and others. Among all disorder types, the anxiety disorder segment is anticipated to continue to lead the global behavioural health market due to a high patient pool globally and high adoption of behavioural health therapy among patients suffering from anxiety issues. According to the WHO, globally 260 million people are suffering from anxiety disorder.

Increased exposure to drugs and alcohol among young adults and strengthening insurance coverage policies for mental health are identified as key trends among end users in the global behavioural health market. Furthermore, rehabilitation programs for substance abuse disorder patients, outpatient counselling for ADHD affected children, and campaigns to spread awareness regarding mental disorders and drug addiction, etc. are some of the major factors that are driving the growth of the global behavioural health market. Government initiatives to reduce the burden of mental illness and rehabilitation services by non-government organizations (NGO) are further expected to positively impact revenue growth of the global behavioural health market.

Ask from Market Research Expert @ https://www.futuremarketinsights.com/ask-question/rep-gb-5375

Global Behavioural Health Market: Competition Analysis

The global market for behavioural health is fragmented with many local and regional level players operating in the worldwide market. Some of the key players featured in the global behavioural health market report include Acadia Healthcare Co., Inc., Universal Health Services Inc., Magellan Health Inc., National Mentor Holdings Inc., Behavioral Health Services Inc., Behavioral Health Network Inc., North Range Behavioral Health, Strategic Behavioral Health LLC, Seton Healthcare Family (Ascension Health) and Ocean Mental Health Services Inc. etc. among others.

Key Segments Covered in Behavioral Health Industry Survey Behavioral Health by Service Type:

  • Outpatient Counselling for Behavioral Health
  • Intensive Case Management for Behavioral Health
  • Home-based Treatment Services for Behavioral Health
  • Inpatient Hospital Treatment for Behavioral Health
  • Emergency Mental Health Service for Behavioral Health
  • Others

Behavioral Health by Disorder Type:

  • Anxiety Disorder
  • ADHD
  • Bipolar Disorders
  • Depression
  • Eating Disorder
  • Post-traumatic Stress Disorder (PTSD)
  • Substance Abuse Disorder
  • Others

Behavioral Health Market by Region:

  • North America Behavioral Health Market
  • Latin America Behavioral Health Market
  • Europe Behavioral Health Market
  • East Asia Behavioral Health Market
  • South Asia & Pacific Behavioral Health Market
  • Middle East & Africa (MEA) Behavioral Health Market

About FMI:

Future Market Insights (ESOMAR certified market research organization and a member of Greater New York Chamber of Commerce) provides in-depth insights into governing factors elevating the demand in the market. It discloses opportunities that will favor the market growth in various segments on the basis of Source, Application, Sales Channel and End Use over the next 9-years.

Contact Us:
Future Market Insights,
Unit No: 1602-006,
Jumeirah Bay 2,
Plot No: JLT-PH2-X2A,
Jumeirah Lakes Towers,
Dubai,
United Arab Emirates
For Sales Enquiries: sales@futuremarketinsights.com
Website: https://www.futuremarketinsights.com
LinkedIn| Twitter| Blogs

Dialysis Equipment Market is projected to surpass a valuation of US$ 23,629.2 Mn by 2032

[318 Pages Report] According to a recent research study published by Future Market Insights, the global dialysis equipment market is projected to register a CAGR of 4.8% and will likely reach a valuation of US$ 23.6 Bn by 2028 end. The medical sector meanwhile continues to introduce newer dialysis equipment in the global market to address the varied needs of patients.

Patients with end-stage renal disease (ESRD) currently have two treatment options – kidney transplant and dialysis. The limited number of kidney donors worldwide and the various medical complications that arise from dialysis have pushed the medical fraternity to look for suitable alternatives to treat ESRD. Implantable bio artificial kidneys are the latest innovation in healthcare science that provide the health benefits of kidney transplantation and potentially wipe out the need for dialysis. Powered by silicon nanotechnology, artificial kidneys seek to eliminate the torture faced by dialysis patients and may prove to be a boon to patients with acute renal failure.

Get a Sample Copy of the Report@ https://www.futuremarketinsights.com/reports/sample/REP-GB-711

In a new development, the Kidney Research Institute of the University of Washington is currently developing a wearable artificial kidney that is expected to go into clinical trials in 2022. This could be a game changer in the medical devices sector, and may reduce the dependency on dialysis equipment to a great extent.

Dialysis Continues to Remain Dominant Therapy to Treat ESRD

While developments in the global healthcare sector continue to focus on innovative products and therapies, dialysis is currently the most administered treatment option for ESRD. Dialysis equipment is in great demand in hospitals, clinics, and dialysis centres across the world, boosting demand in the global market. According to a recent research study published by Future Market Insights, the global dialysis equipment market is projected to register a CAGR of 4.8% and will likely reach a valuation of US$ 23.6 Bn by 2028 end. The medical sector meanwhile continues to introduce newer dialysis equipment in the global market to address the varied needs of patients.

Portable Home Dialysis Equipment Trending the Global Market

Home dialysis has remained a preferred option for patients with renal disease as it is more convenient and less expensive than hospital based dialysis. Leading medical devices manufacturer Quanta has recently launched advanced haemodialysis equipment with an objective to improve the lives of patients requiring dialysis on a regular basis. This is an extremely flexible dialysis treatment that patients can take in the comfort of their homes. Quanta’s home dialysis equipment is portable, lightweight, and very easy to use. This dialysis equipment also incorporates advanced technology such as high-res screens with touchscreen functionalities and helps enhance patient outcomes.

Manufacturers of dialysis equipment are developing fully automatic, portable, and advanced dialysis equipment to treat patients of all ages suffering from ESRD. A notable technological advancement includes the introduction of high-efficiency and high-flux membranes, enabled by technical advances in membrane technology and polymer chemistry. Unlike traditional renal replacement machines, automated dialysis equipment facilitates the management of disease parameters digitally, thereby ensuring more accuracy and reducing costs of labour.

For critical insights, request for PDF Brochure – https://www.futuremarketinsights.com/reports/brochure/rep-gb-711

Wearable Dialysis Equipment to Ease Patient Discomfort; Expected to Rule the Global Market

With technology having proliferated every aspect of human lives, the innovation of wearable dialysis equipment is a blessing for countless dialysis patients, who can now break the shackles of confinement to fixed dialysis equipment and enjoy increased mobility. Wearable dialysis equipment is a miniature artificial HD machine based on dialysate regenerating sorbent technology. Designed for use as a belt, patients can wear this dialysis equipment for slow, gentle dialysis. This dialysis equipment is touted to best mimic the natural kidney function of blood cleansing. Given the continuous advancements taking place in medical device technology, wearable dialysis equipment may soon emerge in a more compact and small form factor to provide increased convenience and usability to patients.

Why Future Market Insights?

• Comprehensive analysis on evolving purchase pattern across different geographies
• Detailed insights of market segments and sub-segments for historical as well as forecast period
• A competitive analysis of prominent players and emerging players in the keyword market
• Detailed information about the product innovation, mergers and acquisitions lined up in upcoming years

Ground breaking research and market player-centric solutions for the upcoming decade according to the present market scenario

About FMI:

Future Market Insights (ESOMAR certified market research organization and a member of Greater New York Chamber of Commerce) provides in-depth insights into governing factors elevating the demand in the market. It discloses opportunities that will favor the market growth in various segments on the basis of Source, Application, Sales Channel and End Use over the next 9-years.

Contact Us:
Future Market Insights,
Unit No: 1602-006,
Jumeirah Bay 2,
Plot No: JLT-PH2-X2A,
Jumeirah Lakes Towers,
Dubai,
United Arab Emirates
For Sales Enquiries: sales@futuremarketinsights.com
Website: https://www.futuremarketinsights.com
LinkedIn| Twitter| Blogs

Muscle Stimulation Devices Market is anticipated to expand at a CAGR of 3.9% by 2028 | FMI

The performance of the global muscle stimulation devices market is expected to witness immensely impactful developments, with potential improvements in the recovery of stroke through nerve stimulation. With rising rate of AIS (acute ischemic stroke), the focus has been shifted to improving the associated stages of stroke care, including prevention, intervention, and rehabilitation. The Ohio State University has been conducting a new clinical trial to shorten the motor skills recovery period in stroke patients, via VNS (vagus nerve stimulation).

Request For Sample Report @ https://www.futuremarketinsights.com/reports/sample/rep-gb-1140

The trial involves the use of a device – Vivistim, which has been developed by MicroTransponder, a Dallas-based company. The device functions by coupling VNS with the muscle movement, during rehabilitation. It is supposed to build up the motor function, learning, and memory, drastically improving the post-stroke outcome thereby. This nerve stimulation therapy, if used in tandem with appropriate interventions, can potentially result in excellent rehabilitation, minimizing the impact of complications that may follow the treatment process. If Vivistim delivers positive results and enables stroke patients to regain their motor function early, the market participants may witness multiple doors of opportunities in the rehabilitative treatment area.

Key Companies to Focus on Strong Distribution Channel Development & Suppliers to Strengthen Presence in Emerging Markets

New and innovative product launches such as wireless devices are being considered by manufacturers as the key to achieve enhanced device capabilities, which is presumed to trigger sales in long term. To expand market shares and improve distribution network through the next decade, several players are prioritizing strategic partnerships, i.e. distribution agreements for their product offerings. Enhanced distribution will also help the stakeholders penetrate various untapped regional markets.

Any Questions, Reach Out To Us @  https://www.futuremarketinsights.com/ask-question/rep-gb-1140

Key players in the global muscle stimulation devices market are focusing on development of new pain management methods and techniques. Adoption of innovative marketing strategy by muscle stimulation device manufacturers is attributed to their gradually increasing market value share. Increased focus on strengthening of distribution channel will reportedly be the key for market expansion in emerging economies. On the flipside, suppliers are likely to consider patient needs as a top priority, while ensuring the supply of high-quality products to end users. Stakeholders are strengthening product portfolio by launching new products with improved features, and through strategic mergers and acquisitions. Moreover, a growing number of local players in the muscle stimulation devices market is expected to result in creating a fragmented market, since the market is already led by smaller-sized firms catering to domestic customer demands.

Muscle Stimulation Devices to Face Passive Growth

Despite immense scope for innovation in product development and applications, the global market for muscle stimulation devices is projected to observe sluggish growth over the next decade. As prompted by a recent research study by Future Market Insights, the global muscle stimulation devices market will expand at a CAGR of 3.9% during 2018-2028, attaining a value of over US$ 870 Mn by 2028 end. High price point will remain a longstanding factor limiting widespread adoption of muscle stimulators. Stringent regulatory norms regarding the launch and use of muscle stimulation devices is also anticipated to hinder market growth in upcoming decade.

By value, North America and Western Europe are expected to represent the dominant markets for muscle stimulation devices, whereas developing economies such as APEJ, Latin America, and Eastern Europe will reportedly exhibit relatively promising performance over the projection period.

Buy Industry Research Report @ https://www.futuremarketinsights.com/checkout/1140

Key Segments

The next section analyses market on the basis of product type and presents forecast in terms of value (US$ Mn) for the next 10 years. Product types included in the report are-

  • Neuromuscular Electric Stimulator (NMES)
  • Transcutaneous Electric Nerve Stimulator (TENS)
  • Interferential (If)
  • Burst Mode Alternating Current

The next section analyses market on the basis of indication and presents forecast in terms of value (US$ Mn) for the next 10 years The global muscle stimulation devices market is segmented on the basis of application into:

  • Pain Management
  • Neurological & Movement Disorder Management
  • Musculoskeletal Disorder Management

The next section analyses the market on the basis of the end user and presents forecast in terms of value (US$ Mn) for the next 10 years. On the basis of the end user, the global muscle stimulation devices market is categorized into:

  • Hospitals
  • Physiotherapy Clinics
  • Sports Clinics
  • Home Care Settings

About FMI:

Future Market Insights (ESOMAR certified market research organization and a member of Greater New York Chamber of Commerce) provides in-depth insights into governing factors elevating the demand in the market. It discloses opportunities that will favor the market growth in various segments on the basis of Source, Application, Sales Channel and End Use over the next 9-years.

Contact Us:
Future Market Insights,
Unit No: 1602-006,
Jumeirah Bay 2,
Plot No: JLT-PH2-X2A,
Jumeirah Lakes Towers,
Dubai,
United Arab Emirates
For Sales Enquiries: sales@futuremarketinsights.com
Website: https://www.futuremarketinsights.com
LinkedIn| Twitter| Blogs